Literature DB >> 12167243

Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis.

Jeff G Leid1, J W Costerton, Mark E Shirtliff, Michael S Gilmore, Michael Engelbert.   

Abstract

Endophthalmitis is an important disease of the eye that is most frequently caused by postoperative and post-traumatic introduction of bacteria into the posterior segment of the eye. In the case of severe infections, visual acuity is greatly damaged or completely lost. Much work has focused on the ability of planktonic bacteria to cause infection and ocular damage while little work has focused on chronic infections in endophthalmitis mediated by the formation of bacterial biofilms on the surface of the lens. This review focuses on the interaction of Staphylococcus aureus and Staphylococcus epidermidis lens-associated biofilms in endophthalmitis. Additionally, this review highlights some relevant biofilm-immune system interactions and outlines a new in vivo mouse model to explore biofilm-related infections in endophthalmitis.

Entities:  

Mesh:

Year:  2002        PMID: 12167243     DOI: 10.1089/10445490260099692

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  11 in total

1.  Activation of phagocytic cells by Staphylococcus epidermidis biofilms: effects of extracellular matrix proteins and the bacterial stress protein GroEL on netosis and MRP-14 release.

Authors:  Ulrike Dapunt; Matthias M Gaida; Eva Meyle; Birgit Prior; Gertrud M Hänsch
Journal:  Pathog Dis       Date:  2016-04-23       Impact factor: 3.166

2.  Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus.

Authors:  Travis Kochan; Anuj Singla; Joaquin Tosi; Ashok Kumar
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

3.  A microbiological and confocal microscopy study documenting a slime-producing Staphylococcus epidermidis isolated from a nylon corneal suture of a patient with antibiotic-resistant endophthalmitis.

Authors:  Carlo Nucci; Marco Artini; Mark Pasmore; Filippo Missiroli; J William Costerton; Laura Selan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

Review 4.  Staphylococcus aureus biofilms: properties, regulation, and roles in human disease.

Authors:  Nathan K Archer; Mark J Mazaitis; J William Costerton; Jeff G Leid; Mary Elizabeth Powers; Mark E Shirtliff
Journal:  Virulence       Date:  2011-09-01       Impact factor: 5.882

5.  In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis.

Authors:  Deepa Talreja; Pawan Kumar Singh; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-12       Impact factor: 4.799

Review 6.  Wound biofilms: lessons learned from oral biofilms.

Authors:  Kimberly A Mancl; Robert S Kirsner; Dragana Ajdic
Journal:  Wound Repair Regen       Date:  2013-04-01       Impact factor: 3.617

7.  Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis.

Authors:  Pawan Kumar Singh; David M Donovan; Ashok Kumar
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

8.  The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus.

Authors:  Kimberly K Jefferson; Danielle B Pier; Donald A Goldmann; Gerald B Pier
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

Review 9.  The Pathogenesis of Staphylococcus aureus Eye Infections.

Authors:  Richard J O'Callaghan
Journal:  Pathogens       Date:  2018-01-10

10.  Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing.

Authors:  Scot E Dowd; Yan Sun; Patrick R Secor; Daniel D Rhoads; Benjamin M Wolcott; Garth A James; Randall D Wolcott
Journal:  BMC Microbiol       Date:  2008-03-06       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.